Roche outlines $680m saving in Corange deal
This article was originally published in Clinica
Executive Summary
Roche has outlined restructuring plans while it continues confidential discussions with the European Commission over market share if its proposed acquisition of Corange's two businesses, Boehringer Mannheim and DePuy goes through.